Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
出版年份 2020 全文链接
标题
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
作者
关键词
-
出版物
Molecular Cancer
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-27
DOI
10.1186/s12943-020-01197-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis
- (2020) Chunyong Han et al. Aging-US
- Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
- (2020) Pan Wu et al. Molecular Cancer
- LY6K Promotes Glioblastoma Tumorigenicity via CAV-1-Mediated ERK1/2 Signaling Enhancement
- (2020) Namratha G Sastry et al. NEURO-ONCOLOGY
- The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically
- (2020) Zhibin Yu et al. ONCOGENE
- SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms
- (2020) Jing He et al. ONCOGENE
- RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice
- (2020) Antje M. Richter et al. ONCOGENE
- circRNA circFUT8 Upregulates Krüpple-like Factor 10 to Inhibit the Metastasis of Bladder Cancer via Sponging miR-570-3p
- (2020) Qingqing He et al. Molecular Therapy-Oncolytics
- Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma
- (2020) Moritz Reese et al. Cancers
- A Comprehensive Picture of Extracellular Vesicles and Their Contents. Molecular Transfer to Cancer Cells
- (2020) Ancuta Jurj et al. Cancers
- Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4
- (2020) Dong Ha Kim et al. CANCER LETTERS
- Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy
- (2019) David Zahavi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The histone H3 Lys 27 demethylase KDM6B promotes migration and invasion of glioma cells partly by regulating the expression of SNAI1
- (2019) Aixia Sui et al. NEUROCHEMISTRY INTERNATIONAL
- Preclinical Targeting of MicroRNA-214 in Cutaneous T-cell Lymphoma (CTCL)
- (2019) Rebecca Kohnken et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The role of m6A RNA methylation in human cancer
- (2019) Xiao-Yu Chen et al. Molecular Cancer
- The Potential for microRNA Therapeutics and Clinical Research
- (2019) Johora Hanna et al. Frontiers in Genetics
- Colorectal cancer-derived extracellular vesicles induce transformation of fibroblasts into colon carcinoma cells
- (2019) Mohamed Abdouh et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
- (2019) Xiaofan Ding et al. GASTROENTEROLOGY
- Current concepts of non-coding RNA regulation of immune checkpoints in cancer
- (2019) Maria Anna Smolle et al. MOLECULAR ASPECTS OF MEDICINE
- Exosomes in Cancer Radioresistance
- (2019) Jie Ni et al. Frontiers in Oncology
- NSD2 overexpression drives clustered chromatin and transcriptional changes in a subset of insulated domains
- (2019) Priscillia Lhoumaud et al. Nature Communications
- microRNA-181 serves as a dual-role regulator in the development of human cancers
- (2019) Tayebeh Rezaei et al. FREE RADICAL BIOLOGY AND MEDICINE
- Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
- (2019) Alexandre Teixeira Vessoni et al. ONCOGENE
- The Bivalent Genome: Characterization, Structure, and Regulation
- (2019) Enrique Blanco et al. TRENDS IN GENETICS
- Zebularine exerts its antiproliferative activity through S phase delay and cell death in human malignant mesothelioma cells
- (2018) Yukitoshi Takemura et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
- (2018) Binghao Li et al. CANCER RESEARCH
- LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
- (2018) Wanqiang Sheng et al. CELL
- Multiple functions of m6A RNA methylation in cancer
- (2018) Yutian Pan et al. Journal of Hematology & Oncology
- Next generation of immune checkpoint therapy in cancer: new developments and challenges
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Enhancer of zeste homolog 2 (EZH2) inhibitors
- (2018) Nitya Gulati et al. LEUKEMIA & LYMPHOMA
- DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer
- (2018) He Cui et al. ONCOGENE
- Therapeutic Targeting of Long Non-Coding RNAs in Cancer
- (2018) Gayatri Arun et al. TRENDS IN MOLECULAR MEDICINE
- DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer
- (2018) Na Luo et al. Nature Communications
- EZH2 inhibitors sensitize myeloma cell lines to panobinostat resulting in unique combinatorial transcriptomic changes
- (2018) Taylor Harding et al. Oncotarget
- DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
- (2018) Varun Sasidharan Nair et al. Clinical Epigenetics
- Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
- (2018) Youn H Kim et al. LANCET ONCOLOGY
- FDA approves patisiran to treat hereditary transthyretin amyloidosis
- (2018) Heather Wood Nature Reviews Neurology
- DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
- (2018) Varun Sasidharan Nair et al. Clinical Epigenetics
- Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
- (2018) Diana Llopiz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- BRD4 and Cancer: going beyond transcriptional regulation
- (2018) Benedetta Donati et al. Molecular Cancer
- IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner
- (2018) Simon Müller et al. NUCLEIC ACIDS RESEARCH
- Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma
- (2018) Dong Jiang et al. Cell Death & Disease
- Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis
- (2018) Zhicheng Zeng et al. Nature Communications
- Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL -negative acute lymphoblastic leukemia
- (2017) Benjamin Kobitzsch et al. HAEMATOLOGICA
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
- (2017) Nico van Zandwijk et al. LANCET ONCOLOGY
- Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer
- (2017) Sayyed K. Zaidi et al. MOLECULAR AND CELLULAR BIOLOGY
- RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN
- (2017) Valentina Sancisi et al. NUCLEIC ACIDS RESEARCH
- Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL -negative acute lymphoblastic leukemia
- (2017) Benjamin Kobitzsch et al. HAEMATOLOGICA
- The Role of Panobinostat Plus Bortezomib and Dexamethasone in Treating Relapsed or Relapsed and Refractory Multiple Myeloma: A European Perspective
- (2016) Jesus F. San-Miguel et al. ADVANCES IN THERAPY
- The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects
- (2016) J. Shahbazi et al. CLINICAL CANCER RESEARCH
- Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity
- (2016) Terri L. Messier et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study
- (2016) Michael Bitzer et al. JOURNAL OF HEPATOLOGY
- METTL3 Gains R/W Access to the Epitranscriptome
- (2016) Ulrike Schumann et al. MOLECULAR CELL
- m6A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination
- (2016) Irmgard U. Haussmann et al. NATURE
- An essential role for UTX in resolution and activation of bivalent promoters
- (2016) Shilpa S. Dhar et al. NUCLEIC ACIDS RESEARCH
- Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells
- (2016) S Gupta et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus
- (2016) Ramiro Vázquez et al. Oncotarget
- BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
- (2016) Hengrui Zhu et al. Cell Reports
- High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML
- (2016) Yue Zhao et al. Cell Reports
- Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
- (2016) Céline Berthon et al. Lancet Haematology
- Abstract 2625: Targeting prostate cancer stem cells (CSCs) with the novel BET bromodomain (BRD) protein inhibitor OTX015
- (2015) Gianluca Civenni et al. CANCER RESEARCH
- Targeting EZH2 and PRC2 dependence as novel anticancer therapy
- (2015) Bowen Xu et al. EXPERIMENTAL HEMATOLOGY
- Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma
- (2015) Paul G Richardson et al. Expert Review of Anticancer Therapy
- A majority of m6A residues are in the last exons, allowing the potential for 3′ UTR regulation
- (2015) Shengdong Ke et al. GENES & DEVELOPMENT
- Relationship between LSD1 expression and E-cadherin expression in prostate cancer
- (2015) Min Wang et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- N6-methyladenosine marks primary microRNAs for processing
- (2015) Claudio R. Alarcón et al. NATURE
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
- (2015) Philipp Rathert et al. NATURE
- RNA–RNA interactions in gene regulation: the coding and noncoding players
- (2015) Sonia Guil et al. TRENDS IN BIOCHEMICAL SCIENCES
- How Does Multistep Tumorigenesis Really Proceed?
- (2015) Christine L. Chaffer et al. Cancer Discovery
- NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect
- (2015) Toshiki Etani et al. Oncotarget
- TET proteins and the control of cytosine demethylation in cancer
- (2015) Laurianne Scourzic et al. Genome Medicine
- Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome
- (2015) Oncotarget
- In VitroAntiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122
- (2014) Søren Ottosen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics
- (2014) Jiří Mayer et al. BMC CANCER
- Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4′-thio-2′-deoxycytidine and 5-aza-4′-thio-2′-deoxycytidine
- (2014) Jaideep V. Thottassery et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Loss of the Polycomb Mark from Bivalent Promoters Leads to Activation of Cancer-Promoting Genes in Colorectal Tumors
- (2014) M. A. Hahn et al. CANCER RESEARCH
- Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase
- (2014) Xiao-Li Ping et al. CELL RESEARCH
- Long Noncoding RNAs as Putative Biomarkers for Prostate Cancer Detection
- (2014) Bongyong Lee et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
- (2014) Hariharan Easwaran et al. MOLECULAR CELL
- Detecting and characterizing circular RNAs
- (2014) William R Jeck et al. NATURE BIOTECHNOLOGY
- Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis
- (2014) S Josson et al. ONCOGENE
- Perturbation of m6A Writers Reveals Two Distinct Classes of mRNA Methylation at Internal and 5′ Sites
- (2014) Schraga Schwartz et al. Cell Reports
- An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors
- (2013) A. C. West et al. CANCER RESEARCH
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Tet family of 5-methylcytosine dioxygenases in mammalian development
- (2013) Hongbo Zhao et al. JOURNAL OF HUMAN GENETICS
- A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
- (2013) Jianzhao Liu et al. Nature Chemical Biology
- BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models
- (2013) Anastasia Wyce et al. PLoS One
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition
- (2013) Gabriel G Malouf et al. GENOME BIOLOGY
- The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo
- (2012) Wei Tan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
- (2012) C. J. Ott et al. BLOOD
- The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
- (2012) T. Gutschner et al. CANCER RESEARCH
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
- (2012) Kate D. Meyer et al. CELL
- Aberrant DNA Methylation and Prostate Cancer
- (2012) Sunipa Majumdar et al. CURRENT GENOMICS
- Effect of valproic acid on mitochondrial epigenetics
- (2012) Hu Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy
- (2012) Samir E. Witta et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib
- (2012) Anja Lachenmayer et al. JOURNAL OF HEPATOLOGY
- Therapy with the histone deacetylase inhibitor pracinostat for patients with myelofibrosis
- (2012) Alfonso Quintás-Cardama et al. LEUKEMIA RESEARCH
- Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer
- (2012) Myung-Ju Ahn et al. LUNG CANCER
- Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
- (2012) Joshua C. Black et al. MOLECULAR CELL
- ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
- (2012) Guanqun Zheng et al. MOLECULAR CELL
- Landscape of transcription in human cells
- (2012) Sarah Djebali et al. NATURE
- Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
- (2012) Panagiotis Ntziachristos et al. NATURE MEDICINE
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
- (2012) W. W. Lockwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EZH2 Goes Solo
- (2012) G. Cavalli SCIENCE
- A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma
- (2011) John D. Hainsworth et al. CANCER INVESTIGATION
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders
- (2011) Josef Finsterer et al. Expert Opinion on Drug Metabolism & Toxicology
- Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors
- (2011) Giuseppe Giaccone et al. JOURNAL OF CLINICAL ONCOLOGY
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
- (2011) Guifang Jia et al. Nature Chemical Biology
- Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis
- (2011) V Davalos et al. ONCOGENE
- EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis
- (2010) I. Velichutina et al. BLOOD
- CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
- (2010) Cheng-Jung Lai et al. CANCER RESEARCH
- Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer
- (2010) Erik D. Wiklund et al. INTERNATIONAL JOURNAL OF CANCER
- Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo
- (2010) Andelko Hrzenjak et al. Molecular Cancer
- Role for DNA Methylation in the Regulation of miR-200c and miR-141 Expression in Normal and Cancer Cells
- (2010) Lukas Vrba et al. PLoS One
- Targeting DNA methylation for epigenetic therapy
- (2010) Xiaojing Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Azacytidine Inhibits RNA Methylation at DNMT2 Target Sites in Human Cancer Cell Lines
- (2009) M. Schaefer et al. CANCER RESEARCH
- Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer
- (2009) D. S. Welsbie et al. CANCER RESEARCH
- Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, with Chemotherapy for the Treatment of Soft Tissue Sarcoma
- (2009) G. Lopez et al. CLINICAL CANCER RESEARCH
- Human DNA methylomes at base resolution show widespread epigenomic differences
- (2009) Ryan Lister et al. NATURE
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
- (2008) Carlo Stresemann et al. INTERNATIONAL JOURNAL OF CANCER
- Role of the Histone H3 Lysine 4 Methyltransferase, SET7/9, in the Regulation of NF-κB-dependent Inflammatory Genes
- (2008) Yan Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
- (2008) Xiaohua Shen et al. MOLECULAR CELL
- DNA methylation in development and human disease
- (2008) Suhasni Gopalakrishnan et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More